跳至主要内容
临床试验/DRKS00008916
DRKS00008916已完成未知

Philips Digital Breast Tomosynthesis trial for CE markets

Philips Digital Mammography Sweden AB0 个研究点目标入组 38 人开始时间: 2015年9月23日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
38

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomized controlled study
盲法
Blinded (masking used)

入排标准

年龄范围
40 Years 至 one(—)
性别
Female

入选标准

  • Patient is female and 40 years of age or older
  • - Patient will be undergoing a biopsy for a screening-detected abnormality or after presenting with clinical symptoms (e g palpable lump, nipple discharge, nipple retraction, skin irritation or dimpling)
  • - Patient underwent a 2D mammography (FFDM) in this institution with a Philips MicroDose SI L50 or Philips MicroDose L30 system less than 30 days prior to the day of imaging with the investigational device

排除标准

  • - Patient is pregnant or believes she may be pregnant; OR,
  • - Patient is breast feeding; OR
  • - Patient is unable or unwilling to give informed consent, including consent to reuse data for future research; OR
  • - Patient has been part of another clinical trial within last 12 months

研究者

相似试验

Philips Digital Breast Tomosynthesis trial for CE... | 临床试验